Adenovirus (Ad) type 4 and 7 vaccines effectively controlled observed, the cells were scraped and resuspended in culture Ad infections in a military population, but the virus reemerged medium, spotted, and stained with Ad-specific fluorescenceas a major cause of acute respiratory disease when vaccine labeled monoclonal antibody (Chemicon International, Teproduction was stopped (1, 4, 5) . This prompted the Departmecula, Calif.). ment of Defense to establish surveillance for Ad infections Simplified microneutralization. An assay medium consisting among trainees to determine the serotype distribution and to of Eagle's minimum essential medium in Earle's balanced salt assess the effect of vaccine loss. Because of large numbers of solution, fetal bovine serum (10%), NaHCO 3 (0.09 g), L-gluAds isolated, an efficient and rapid method for serotyping tamine (2 mM), penicillin (200 U/ml), streptomycin (200 R1g/ isolates was devised. ml), and Fungizone (1.0 pRg/ml) was used in the test. Single Ad serotype classification by neutralization with type-spedilutions (10 [xl) of type-specific hyperimmune rabbit sera were cific antisera in a microplate format has been previously deloaded in each well and diluted with 40 R.1 of assay medium. scribed (2, 3, 6) . This technique requires prior titration of viral
Isolates were vortexed, diluted 1:10, and loaded into desigisolates to determine the virus challenge dose and takes 3 to 7 nated wells at 50 pxl per well. The infectivities of the isolates days to complete. In this report, we describe a simplified miwere assayed in a logarithmic serial dilution using 50 RIl of the croneutralization test using an empirically determined virus isolate at 1:10 dilution. The plates were incubated for 1 h at dilution and a single antiserum concentration. This research 37°C in 5% C0 2 , and then 5,000 A549 cells were added to each has been conducted in compliance with all applicable federal well. The plates were further incubated for 7 days and observed regulations governing the protection of human subjects in reafter 72 h and on days 5 and 7. The serotypes were determined search.
by inhibition of CPE in wells containing type-specific anti-A549 cells (American Type Culture Collection, Manassas, serum. Isolates not neutralized by any antiserum were retested Va.) were maintained by monthly subculturing at a 1:4 split at the dilution where 75% CPE was first observed in the inratio, using Eagle's minimum essential medium in Earle's balfectivity assay. Isolates that did not type after repeat tests were anced salt solution, fetal bovine serum (10%), antibiotics, and considered nontypeable. amino acids (Biowhittaker, Walkersville, Md.). Prototype Ads Validation. Blinded to the serotype results, VRDL validated were purchased from the American Type Culture Collection 105 randomly selected isolates using the colorimetric microand subpassaged in A-549 cells. Type-specific rabbit immune neutralization test described elsewhere (2). Serial 2-fold dilusera to Ad types I to 5, 7, and 21 (Viral and Rickettsial Disease Laboratory [VRDL] , California Department of Health Sertinofheyp-ecicyermuesadsrbdaov vicesaBerkly , Calif.)wreia sta ardizednto contan 2eanti-were used. The criterion for confirmation of a serotype was for b ites, perkeley, 10lif.) weah stant zdy unto coneutralizs 0 5-the isolate to be neutralized by a dilution of the type-specific bodyunis pe 10Rl.Eachantbod uni netraizes10050% serum within 16-fold of the titer of the same serum required to tissue culture infective doses (TCID 5 o) of the prototype virus.
serumiwithi 1-olothe tiru of the same sue quire to The serotypes used in the test were those most frequently neutralize the prototype virus. The type identification was conassociated with respiratory disease (7). sidered confirmed when the titer of the isolate was at least 32 Ad surveillance was conducted from October 1996 to June TCID, 0 and the neutralization titer observed was within 16-1998 (5) among symptomatic military recruits from four trainfold of the titer observed when the same antiserum was tested ing camps in the United States. Throat specimens were inocagainst the homologous prototype virus. ulated into A-549 cells. When 75% cytopathic effect (CPE) was One thousand eight hundred fourteen (53.1%) of the total 3,413 throat swabs collected were positive for Ad. Serotyping I I Not re-tested:
6
"Typed after re-testing using the same dilution: 31
Typed after re-testinp using a different dilution: 72
Failed to type after re-testing: 9 FIG. 1. Data analysis flow chart for microneutralization results.
isolates required additional attention ( Fig. 1) : 141 required croneutralization test with the standard test for 99 of 105 retesting due to all serotype wells showing CPE (n = 118), two selected isolates. Two type 2 isolates could not be validated wells showing CPE (n = 13), or no wells showing CPE (n = because of coinfection with another virus. Upon retest by the 10); 18 had discrepant results after they were inadvertently simplified procedure, two of the four discrepant isolates were tested twice; and 16 were contaminated with other organisms.
in agreement with the standard (Table 1 ). The two remaining Of the 118 isolates that were CPE positive with all antisera discrepant isolates were retested by VRDL, and serotype used, 31 typed after retesting using the same virus dilution, 72 agreement was established. After these adjustments, a 98% typed after retesting at a dilution where 75% CPE was first concordance was observed between the results of the simpliobserved in back titration, and 9 failed to type after retesting fled microneutralization test and those of the standard test. (Fig. 1) . The remaining six isolates were not retested.
The highly concentrated antiserum used in the simplified All 13 isolates exhibiting two serotypes were successfully procedure was the key factor in the successful performance of typed upon retesting. The 10 isolates that were CPE negative the test. Each antiserum was standardized to contain 20 antiwith all antisera used were not retested. Of the samples tested, body units that neutralize 100 TCID 5 o of the prototype at a 1,697 (97.4%) were successfully typed. Overall, 4 (0.2%) of the 20-fold dilution, making it possible to use an approximate test isolates were Ad type 1, 32 (1.9%) were type 2, 142 (8.4%) dilution, thereby cutting the assay time from 14 to 7 days. were type 3, 974 (57.4%) were type 4, 407 (24.0%) were type 7, Our results indicate that the simplified microneutralization and 138 (8.1%) were type 21.
test works well with rapidly growing, relatively high-Ad-titer Validation results revealed agreement of the simplified miviral isolates but may not perform as well for serotypes which 
